Medpage Today on MSN3 天
Expanded Treatment Options for Primary Biliary Cholangitis Leave Open Questions
The approval of ursodeoxycholic acid (UDCA) for primary biliary cholangitis (PBC) in 1997 marked a pivotal turning point in ...
Pharmaceutical Technology4 天
Advanz Pharma’s liver disease drug pulled from European market after court hearing
This latest update comes after Advanz secured a suspension of the European Commission’s original revocation in September 2024 ...